MeMed Further Solidifies Board of Directors Appointing Scott Garrett
09. November 2023 09:00 ET
|
MeMed
MeMed Further Solidifies Board of Directors with Appointment of Scott Garrett HAIFA, Israel; BOSTON, MA – 9 November, 2023 – MeMed, a leader in host response technologies, today announces the...
MeMed Bolsters Leadership Team With Appointment of Ori Hadomi as Chairman and Peter Scheu as President of MeMed US
06. November 2023 02:00 ET
|
MeMed
MeMed Bolsters Leadership Team With Appointment of Ori Hadomi as Chairman and Peter Scheu as President of MeMed US HAIFA, Israel; BOSTON, MA – 6 November, 2023 – MeMed, a leader in host response...
MeMed awarded US BARDA contract to demonstrate clinical utility of the FDA-cleared MeMed BV® test for distinguishing bacterial from viral infections
24. Oktober 2023 07:00 ET
|
MeMed
Contract awarded under the BARDA DRIVe (Division of Research, Innovation, and Ventures) initiative to harness a patient's systemic response to inform on health threats and clinical impact TIRAT...
MeMed awarded US BARDA contract to demonstrate clinical utility of the FDA-cleared MeMed BV® test for distinguishing bacterial from viral infections
24. Oktober 2023 07:00 ET
|
MeMed
Contract awarded under the BARDA DRIVe (Division of Research, Innovation, and Ventures) initiative to harness a patient's systemic response to inform on health threats and clinical impact TIRAT...
MeMed: FDA Clears Pioneering MeMed BV Test Direct From Whole Blood Allowing Faster Time To Result And Broader Patient Access When Distinguishing Bacterial From Viral Infections
19. Juli 2023 07:00 ET
|
MeMed
FDA Clears Pioneering MeMed BV Test Direct From Whole Blood Allowing Faster Time To Result And Broader Patient Access When Distinguishing Bacterial From Viral Infections Opens up testing to...
MeMed: FDA Clears Pioneering MeMed BV Test Direct From Whole Blood Allowing Faster Time To Result And Broader Patient Access When Distinguishing Bacterial From Viral Infections
19. Juli 2023 02:00 ET
|
MeMed
FDA Clears Pioneering MeMed BV Test Direct From Whole Blood Allowing Faster Time To Result And Broader Patient Access When Distinguishing Bacterial From Viral Infections Opens up testing to...
MeMed: Nutex Health Announces Agreement with MeMed to Adopt Pioneering MeMed BV® Test Across its Network of 19 sites
25. Mai 2023 08:00 ET
|
MeMed
Nutex Health Announces Agreement with MeMed to Adopt Pioneering MeMed BV® Test Across its Network of 19 sites Following successful partnerships with Tucson ER & Hospital and Tulsa ER &...
Clinical data validate pioneering MeMed BV technology improves diagnosis of pediatric patients with fever in the Emergency Department
18. April 2023 02:00 ET
|
MeMed
Clinical data validate pioneering MeMed BV technology improves diagnosis of pediatric patients with fever in the Emergency Department Bacterial and viral infections are often clinically...
Tulsa ER & Hospital Adopts Trailblazing MeMed BV® Test
22. Dezember 2022 08:00 ET
|
MeMed
Tulsa ER & Hospital Adopts Trailblazing MeMed BV® Test Tulsa ER & Hospital is the first hospital facility in Oklahoma to adopt the FDA-approved technology that distinguishes viral...
Tucson ER & Hospital Adopts Trailblazing MeMed BV® Test
25. Oktober 2022 10:00 ET
|
MeMed
Tucson ER & Hospital Adopts Trailblazing MeMed BV® Test Tucson ER & Hospital is the first community-based, stand-alone ER and Hospital facility to adopt the FDA-approved technology that...